Transmission of hepatitis c virus through transplanted organs and tissue - Kentucky and Massachusetts, 2011

Morbidity and Mortality Weekly Report

Volumn 60, Issue 50, 2011, Pages 1697-1700

  Marvin, Michael R ^a   Steele, Melissa ^a   Green, Sharon K ^b   Thoroughman, Doug ^c   Sugg, Tennis J ^c   Humbaugh, Kraig E ^c   Vaz, Louise E ^d   Burchett, Sandra K ^d   Moffitt, Kristin ^d   Nielsen, Carrie F ^e   Holmberg, Scott D ^e   Drobeniuc, Jan ^e   Khudyakov, Yury ^e   Kuehnert, Matthew J ^f   Hocevar, Susan N ^f   Mahajan, Reena ^g  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b Magoffin County Health Dept   (United States)

^c Kentucky Department for Public Health   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; ARTICLE; CASE REPORT; DISEASE TRANSMISSION; DONOR; FEMALE; GENETICS; HEALTH CARE FACILITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; UNITED STATES;

ADULT; ANTIBODIES, VIRAL; FALSE NEGATIVE REACTIONS; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; KENTUCKY; MALE; MASSACHUSETTS; MIDDLE AGED; ORGAN TRANSPLANTATION; TISSUE BANKS; TISSUE DONORS;

EID: 84255198581     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Health Resources and Services Administration. Minimum procurement standards for an Organ Procurement Organization (OPO). Rockville, MD: Health Resources and Services Administration; 2011. Available at http://optn.transplant.hrsa.gov/policiesandbylaws2/policies/pdfs/policy_2.pdf Accessed December 19, 2011.
2. Felsentein J. Evolutionary trees from DNA sequences: a maximum likelihood approach. J Mol Evol 1981;17:368-76.
3. Ramachandran S, Xia GL, Ganova-Raeva LM, Nainan OV, Khudyakov Y. End-point limiting-dilution real-time PCR assay for evaluation of hepatitis C virus quasispecies in serum: performance under optimal and suboptimal conditions. J Virol Methods 2008;151:217-24.
4. Tugwell BD, Patel PR, Williams IT, et al. Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor. Ann Intern Med 2005;143:648-54.
5. Ellingson K, Seem D, Nowicki M, Strong DM, Kuehnert MJ, Organ Procurement Organization Nucleic Acid Testing Yield Project Team. Estimated risk of human immunodeficiency virus and hepatitis C virus infection among potential organ donors from 17 organ procurement organizations in the United States. Am J Transplant 2011;11:1201-8.
6. Kleinman SH, Lelie N, Busch MP. Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion 2009;49:2454-89.
7. Draft PHS guideline for reducing transmission of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) through solid organ transplantation. Available at http://www.regulations.gov. Enter: ID = CDC-2011-0011. Accessed December 19, 2011.
8. Kuehnert MJ, Yorita KL, Holman RC, Strong DM; AABB Tissue Task Force. Human tissue oversight in hospitals: an AABB survey. Transfusion 2007;47:194-200.
9. Strong DM, Seem D, Taylor G, Parker J, Stewart D, Kuehnert MJ. Development of a transplantation transmission sentinel network to improve safety and traceability of organ and tissues. Cell Tissue Bank 2010;11:335-43.
10. Brubaker S, Wilson D. Coding and traceability: cells and tissues in North America. Cell Tissue Bank 2010;11:379-89.